Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Staging
15 results:
1. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with colorectal Carcinoma.
Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
[TBL] [Abstract] [Full Text] [Related]
2. N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast cancer.
Song Y; Zheng C; Tao Y; Huang R; Zhang Q
Med Sci Monit; 2021 Aug; 27():e929615. PubMed ID: 34349094
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
Liu XB; Han C; Sun CZ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
[TBL] [Abstract] [Full Text] [Related]
4. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract] [Full Text] [Related]
5. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
[TBL] [Abstract] [Full Text] [Related]
6. [Expression of candidate tumor suppressor gene N-myc downstream-regulated gene 2 in colon cancer].
Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
[TBL] [Abstract] [Full Text] [Related]
7. [Activity of the National Oncology R&D Consortium in 2004].
Tímár J;
Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
[TBL] [Abstract] [Full Text] [Related]
8. K-RAS point mutation, and amplification of C-myc and C-ERBB2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract] [Full Text] [Related]
9. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
Kolligs FT; Bommer G; Göke B
Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
[TBL] [Abstract] [Full Text] [Related]
10. Critical issues in the evolving management of rectal cancer.
Mohiuddin M; Ahmed MM
Semin Oncol; 1997 Dec; 24(6):732-44. PubMed ID: 9422268
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of c-myc oncogene amplification in colorectal cancer.
Kozma L; Kiss I; Szakáll S; Ember I
Cancer Lett; 1994 Jun; 81(2):165-9. PubMed ID: 8012933
[TBL] [Abstract] [Full Text] [Related]
12. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
Smith DR; Myint T; Goh HS
Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
[TBL] [Abstract] [Full Text] [Related]
13. Molecular genetic alterations as potential prognostic indicators in colorectal carcinoma.
Hamilton SR
Cancer; 1992 Mar; 69(6 Suppl):1589-91. PubMed ID: 1540900
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
[TBL] [Abstract] [Full Text] [Related]
15. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract] [Full Text] [Related]
